IL6 and rheumatoid arthritis: Currently available biological agents for the management of RA are anticytokines (anti-TNFα, anti-IL-1β, or anti-IL-6), anticell therapies (anti-B cell, CTLA-4Ig), and signal inhibitors (JAK inhibitors).